...
首页> 外文期刊>Danishgah-i Ulum-i Pizishki va Khadamat-i Bihdashti-Darmani Shahid Sadugi Yazd. Majallah >Evaluation of Co-Administration of Omperazole with H2 Blockers and Antacids
【24h】

Evaluation of Co-Administration of Omperazole with H2 Blockers and Antacids

机译:奥美拉唑与H2阻滞剂和抗酸剂共同给药的评价

获取原文

摘要

Introduction: Omperazole as a very useful drug in peptic ulcer which needs to be converted to active form and its activation requires acidic enviornments. H2 blockers and antacids can prevent this activation by elevation of pH in the gastrointestinal system thus diminishing omperazole effectiveness. In this study, cases of coadministration of omperazsole with H2 blockers and antiacids has been evaluated.Methods: This descriptive study included 1200 prescriptions containing omperazole alone or in combination with other drugs at the Chamran Pharmaceutical Store of Yazd. Results : In 599 cases, omeprazole was administered with other drugs of which 211 cases (35.3%) was with H2 blockers and116 prescriptions with antiacids. Only in 55 cases (4.6%), both antiacids and H2 blockers were administered in combination with omperazole. Conclusion:On the basis of previous studies and considering the physiology of acid secretion in parietal cells and pharmacological mechanism of drugs used in the treatment of peptic ulcer, coadministration of antacids and H2 blockers with omperazole decrease its efficacy and must therefore be avoided.
机译:简介:哌曲唑在消化性溃疡中非常有用,需要转化为活性形式,并且其活化需要酸性环境。 H2阻滞剂和抗酸剂可以通过提高胃肠道系统中的pH值来阻止这种活化,从而降低了omperazole的有效性。在这项研究中,已评估了奥普拉唑与H2受体阻滞剂和抗酸药合用的情况。方法:该描述性研究包括Yazd Chamran药房的1200处方含有单独的omperazole或与其他药物合用的处方。结果:599例患者与其他药物合用了奥美拉唑,其中211例(35.3%)的患者使用了H2受体阻滞剂和116种抗酸药。仅在55例(4.6%)中,抗酸剂和H2受体阻滞剂与奥美拉唑合用。结论:在先前研究的基础上,考虑到壁细胞分泌酸的生理机制以及用于治疗消化性溃疡的药物的药理机制,抗酸药和H2受体阻滞剂与奥美拉唑合用会降低其疗效,因此必须避免。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号